Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy
Dear Editor, Obstructive hypertrophic cardiomyopathy (oHCM) is a hereditary cardiac condition, affecting 1 in about 500 individuals, characterized by an atypical thickening of the heart muscle, specifically the interventricular septum...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
PAGEPress Publications
2024-11-01
|
| Colecção: | Global Cardiology |
| Assuntos: | |
| Acesso em linha: | https://www.globalcardiology.info/site/article/view/48 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
